Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.
Modan B, Hartge P, Hirsh-Yechezkel G, Chetrit A, Lubin F, Beller U, Ben-Baruch G, Fishman A, Menczer J, Struewing JP, Tucker MA, Wacholder S; National Israel Ovarian Cancer Study Group.
Modan B, et al. Among authors: tucker ma.
N Engl J Med. 2001 Jul 26;345(4):235-40. doi: 10.1056/NEJM200107263450401.
N Engl J Med. 2001.
PMID: 11474660
Free article.